Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes to Offer Roche NimbleGen Micorarrays

NEW YORK (GenomeWeb News) – Genomics services provider ImaGenes has received certification from Roche NimbleGen to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services, Roche NimbleGen said today.

Berlin-based ImaGenes passed a ChIP-chip certification using the NimbleGen Dual-Color workflow and the MS 200 Microarray Scanner to become a certified service provider. This certification enables ImaGenes to process samples for DNA-protein interactions and chromatin structure.

Roche NimbleGen CEO Gerd Maass said in a statement that ImaGenes "will further expand our business in the German market and fuel the basic research that is vital to the personalized healthcare pipeline."

ImaGenes offers a range of research services, including microarray and RT-qPCR applications, next-generation sequencing, and access to a mammalian and vertebrate clone collection.